Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Myomo Inc (MYO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Myomo's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.580 +0.040    +1.13%
11:51:17 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 20,072
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 3.530 - 3.600
Myomo 3.580 +0.040 +1.13%

Myomo Inc Company Profile

 
Get an in-depth profile of Myomo Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

104

Equity Type

ORD

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Contact Information

Address 137 Portland Street 4th Floor
Boston, 02114
United States
Phone 617-996-9058
Fax -
Web myomo.com

Top Executives

Name Age Since Title
Paul R. Gudonis 69 2011 Chairman, President & CEO
Thomas A. Crowley 77 2012 Independent Director
Amy Kathryn Knapp 69 2016 Independent Director
Alexander Y. Shin - - Member of Veteran Advisory Board
Stephen Sanghi 68 2016 Board Advisor
Scott Quilty - - Member of Veteran Advisory Board
Thomas F. Kirk 78 2014 Lead Independent Director
Wayne Smith - 2019 Member of Veteran Advisory Board
Steven Kirshblum - - Member of Scientific Advisory Board
Ross D. Zafonte 62 - Chairman of Scientific Advisory Board
Coleman Nee - - Chairman of Veteran Advisory Board
Deborah Hoffman - - Member of Veteran Advisory Board
John Polanowicz - - Member of Veteran Advisory Board
Mary Ellen Stoykov - - Member of Scientific Advisory Board
Steven C. Cramer - - Member of Scientific Advisory Board
Milton M. Morris 54 2021 Independent Director
George F. Wittenberg - - Member of Scientific Advisory Board
Erica Borggren - - Member of Veteran Advisory Board
Yitzchak Jacobovitz 49 2023 Independent Director
Heather C. Getz 49 2024 Director
Stacy Suskauer - - Member of Scientific Advisory Board
Lorie Gage Richards - 2022 Member of Scientific Advisory Board
Susan Duff - - Member of Scientific Advisory Board
Julie Werner - 2022 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MYO Comments

Write your thoughts about Myomo Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Waylin McCurley
Waylin McCurley Mar 11, 2024 2:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$9 stock
Andreas Plessas
Andreas Plessas Jul 11, 2023 3:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$2 dollars coming
Andreas Plessas
Andreas Plessas Feb 14, 2023 9:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just wait til the CMS news
Conchita Worchester
Conchita Worchester Feb 07, 2023 6:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
fantastic going forward
Andreas Plessas
Andreas Plessas Feb 06, 2023 6:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://finance.yahoo.com/news/myopro-approved-australia-national-disability-210500417.html
penk bayu
penk bayu Sep 17, 2020 1:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
spilit 1000
penk bayu
penk bayu Sep 17, 2020 1:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bank sinarmas
penk bayu
penk bayu Sep 17, 2020 1:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
kirim
Mick West
googleMickWest Sep 16, 2020 5:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They did a one for thirty reverse stock split, which would put your $40 price at $1.33
Mick West
googleMickWest Sep 16, 2020 5:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They are certified to provide their technology through Medicare. Pronto Man where on earth are you getting that shares spiked to $40???? That is far from correct. I nee the long team chart show's some interesting stuff, but its not accurate.
Poronto Man
Poronto Man Sep 16, 2020 5:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Check out the 180 days chart. It was a pump and dump and spiked all the way to 40$I traded it that day and made some money on it
Mick West
googleMickWest Sep 16, 2020 5:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Poronto Man  This is some real news, and it doesn't appear to be very bullish.
Ido Wer
Ido Wer Sep 16, 2020 4:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What happened?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email